APA

Tanaka H., Fujiwara H., Ochi F., Tanimoto K., Casey N., Okamoto S., Mineno J., Kuzushima K., Shiku H., Sugiyama T., Barrett A. J. & Yasukawa M. (20180112). Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Tanaka Hiroki, Fujiwara Hiroshi, Ochi Fumihiro, Tanimoto Kazushi, Casey Nicholas, Okamoto Sachiko, Mineno Junichi, Kuzushima Kiyotaka, Shiku Hiroshi, Sugiyama Takashi, Barrett A John and Yasukawa Masaki. 20180112. Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Tanaka H., Fujiwara H., Ochi F., Tanimoto K., Casey N., Okamoto S., Mineno J., Kuzushima K., Shiku H., Sugiyama T., Barrett A. J. and Yasukawa M. (20180112). Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Tanaka Hiroki, Fujiwara Hiroshi, Ochi Fumihiro, Tanimoto Kazushi, Casey Nicholas, Okamoto Sachiko, Mineno Junichi, Kuzushima Kiyotaka, Shiku Hiroshi, Sugiyama Takashi, Barrett A John and Yasukawa Masaki. Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20180112.